Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03072238
Title Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

prostate adenocarcinoma

Therapies

Abiraterone

Abiraterone + Ipatasertib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | CAN | BEL | AUT


No variant requirements are available.